Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
1Life Healthcare Inc (ONEM)
Sector: Healthcare; Industry: Health Information Services

1Life Healthcare, Inc. operates a membership-based primary care platform. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2019, it had approximately 422,000 members in nine markets in the United States; and 7,000 enterprise clients.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-09-16 Lockhart Kimber D Chief Technology Officer Sell 15,000 $29.31 $439,600 Yes
2020-09-02 Lockhart Kimber D Chief Technology Officer Sell 15,000 $29.85 $447,729 Yes
2020-09-01 Mango Lisa A General Counsel and Secretary Sell 33,300 $30.01 $999,243 Yes
2020-09-01 Diamond Andrew S Chief Medical Officer Sell 62,922 $30.01 $1,888,340 Yes
2020-08-31 Kennedy David P Director Sell 50,000 $29.10 $1,455,003 No
2020-08-27 Rubin Amir Dan Chair, CEO and President Sell 86,611 $29.04 $2,514,906 Yes
2020-08-24 Mango Lisa A General Counsel and Secretary Sell 6,700 $30.00 $201,014 Yes
2020-08-24 Diamond Andrew S Chief Medical Officer Sell 15,677 $29.99 $470,202 Yes
2020-08-20 Diamond Andrew S Chief Medical Officer Sell 31,401 $30.00 $941,873 Yes
2020-08-20 Mango Lisa A General Counsel and Secretary Sell 10,000 $30.00 $300,032 Yes
2020-08-19 Lockhart Kimber D Chief Technology Officer Sell 15,000 $29.51 $442,697 Yes
2020-08-20 Rubin Amir Dan Chair, CEO and President Sell 286,011 $29.71 $8,498,498 Yes
2020-08-17 Mango Lisa A General Counsel and Secretary Sell 21,000 $28.71 $602,881 Yes
2020-08-17 Lockhart Kimber D Chief Technology Officer Sell 15,000 $28.70 $430,488 Yes
2020-08-18 Rubin Amir Dan Chair, CEO and President Sell 300,433 $28.78 $8,646,725 Yes
2020-06-29 Carlyle Group Management L.L.C. 10%-Owner Sell 7,545,000 $29.76 $224,539,200 No

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.